prof. MUDr. Jiří Mayer, CSc.

Professor, Department of Internal Medicine, Hematology and Oncology

correspondence Address:
Jihlavská 340/20, 625 00 Brno

phone:	+420 532 23 3643, 3603
e‑mail:	jiri.mayer@ceitec.muni.cz

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 1665

2024

Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry

BRIOLI Annamaria LOMAIA Elza FABISCH Christian SACHA Tomasz KLAMOVA Hana MOROZOVA Elena GOLOS Aleksandra ERNST Philipp OLSSON-STROMBERG Ulla ŽÁČKOVÁ Daniela NICOLINI Franck E BAO Han CASTAGNETTI Fausto PATKOWSKA Elzbieta MAYER Jiří HIRSCHBUEHL Klaus PODGORNIK Helena PACZKOWSKA Edyta PARRY Anne ERNST Thomas VOSKANYAN Astghik SZCZEPANEK Elzbieta SAUSSELE Susanne FRANKE Georg-Nikolaus KIANI Alexander FABER Edgar KRAUSE Stefan CASADO Luis Felipe LEWANDOWSKI Krzysztof EDER Matthias ANHUT Peter GIL Justyna SUEDHOFF Thomas HEBART Holger HEIBL Sonja PFIRRMANN Markus HOCHHAUS Andreas LAUSEKER Michael

Article in Periodical

Leukemia, year: 2024, volume: 38, edition: 5, DOI
MethScore as a new comprehensive DNA methylation-based value refining the prognosis in acute myeloid leukemia

SESTAKOVA Sarka SALEK Cyril KUNDRAT David CEROVSKA Ela VYDRA Jan JEŽÍŠKOVÁ Ivana FOLTA Adam MAYER Jiří CETKOVSKY Petr REMESOVA Hana

Article in Periodical

CLINICAL EPIGENETICS, year: 2024, volume: 16, edition: 1, DOI
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study

POTT Christiane JURINOVIC Vindi TROTMAN Judith KEHDEN Britta UNTERHALT Michael HEROLD Michael RICHARD van der Jagt JANSSENS Ann KNEBA Michael MAYER Jiří YOUNG Moya SCHMIDT Christian KNAPP Andrea NIELSEN Tina BROWN Helen SPIELEWOY Nathalie HARBRON Chris BOTTOS Alessia MUNDT Kirsten MARCUS Robert HIDDEMANN Wolfgang HOSTER Eva

Article in Periodical

Journal of clinical oncology, year: 2024, volume: 42, edition: 5, DOI
MOLECULAR MECHANISM OF NON-GENETIC ADAPTATION TO BTK INHIBITOR THERAPY IN CLL

ONDRIŠOVÁ Laura ŠEDA Václav HLAVÁČ Kryštof HOFERKOVÁ Eva PAVELKOVÁ Petra KOŠŤÁLOVÁ Lenka FILIP Daniel FARIA ZENI Pedro PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka SIMKOVIC M. VRBACKÝ F. LYSÁK Daniel DAVIDS MS. MARTIN-SUBERO JI. BROWN JR. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

Conference abstract

Year: 2024, type: Conference abstract
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes

PERUSINI Maria Agustina ŽÁČKOVÁ Daniela KIM TaeHyung PAGNANO Katia B B PAVLOVSKY Carolina JEŽÍŠKOVÁ Ivana KVETKOVÁ Anežka JURČEK Tomáš KIM Jaeyoon John YOO Young Seok YI Seongyoon LEE Hyewon KIM Kyoung Ha CHANG Myunghee JOSE-MARIO Capo-Chichi MEDEIROS Jessie ARRUDA Andrea MINDEN Mark D ZHANG Zhaolei ABELSON Sagi MAYER Jiří KIM Dennis Dong Hwan

Article in Periodical

Blood advances, year: 2024, volume: 8, edition: 10, DOI
Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors

JANOVSKÁ Pavlína RADASZKIEWICZ Tomasz Witold PROCHAZKOVA P PRIŠTICOVÁ Ingrid PLEŠINGEROVÁ Hana ČULEN Martin ŠMÍDA Michal BUŠA Daniel LADUNGOVÁ Adriana MAIER Lukáš HAVEL Štěpán MAYER Jiří SCHEER A PARUCH Kamil BRYJA Vítězslav

Conference abstract

Year: 2024, type: Conference abstract
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

GEISSLER Klaus KORISTEK Zdenek BERNAL del Castillo Teresa NOVAK Jan RODRIGUEZ-MACIAS Gabriela METZELDER Stephan K ILLES Arpad MAYER Jiří ARNAN Montserrat KEATING Mary-Margaret KRAUTER Juergen LUNGHI Monia FRACCHIOLLA Nicola Stefano PLATZBECKER Uwe SANTINI Valeria SANO Yuri OGANESIAN Aram KEER Harold LUEBBERT Michael

Article in Periodical

British journal of haematology, year: 2024, volume: 205, edition: 5, DOI
Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial

TROTMAN Judith ZINZANI Pier Luigi SONG Yuqin DELARUE Richard KIM Pil IVANOVA Elena KORDE Rasika MAYER Jiří DE OLIVEIRA Ana C ASSOULINE Sarit E FLOWERS Christopher R BARNES Gisoo

Article in Periodical

Current medical research and opinion, year: 2024, volume: 40, edition: 11, DOI
PILOTNÍ STUDIE SLEDOVÁNÍ ZMĚN SLOŽENÍ STŘEVNÍHO MIKROBIOMU U PACIENTŮ S HEMATOLOGICKOU MALIGNITOU POMOCÍ NANOPÓROVÉHO SEKVENOVÁNÍ

BEZDÍČEK Matěj NYKRÝNOVÁ Markéta KABUT Tomáš WEINBERGEROVÁ Barbora REINEROVÁ Zuzana MAYER Jiří LENGEROVÁ Martina

Conference abstract

Year: 2024, type: Conference abstract
Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment

BROWN Jennifer R EICHHORST Barbara HILLMEN Peter JURCZAK Wojciech KAZMIERCZAK Maciej LAMANNA Nicole O'BRIEN Susan M TAM Constantine S QIU Lugui ZHOU Keshu SIMKOVIC Martin MAYER Jiří GILLESPIE-TWARDY Amanda FERRAJOLI Alessandra GANLY Peter S WEINKOVE Robert GROSICKI Sebastian MITAL Andrzej ROBAK Tadeusz OSTERBORG Anders YIMER Habte A SALMI Tommi WANG Megan-Der-Yu FU Lina LI Jessica WU Kenneth COHEN Aileen SHADMAN Mazyar

Article in Periodical (without peer review)

Year: 2024, type: Article in Periodical (without peer review)

Projects

Teaching